Status:

COMPLETED

Bovine Intestinal Alkaline Phosphatase for the Treatment of Patients With Sepsis

Lead Sponsor:

AM-Pharma

Conditions:

Sepsis

Multiple Organ Dysfunction Syndrome

Eligibility:

All Genders

18-80 years

Phase:

PHASE2

Brief Summary

Eligible patients will receive either AP or matching placebo in a double blind, randomized design and following a 2:1 ratio. All medication will be given in addition to standard care for sepsis patien...

Detailed Description

Both bolus and continuous infusions were found to effectively reduce the LPS-induced pro-inflammatory cytokine TNFα in piglets. When AP was administered as a bolus (160 U/kg), the reduction of TNFα af...

Eligibility Criteria

Inclusion

  • Patients between 18 and 80 years (inclusive);
  • proven or suspected infection;
  • meeting 2 of 4 of the systemic inflammatory response syndrome (SIRS) criteria;
  • septic shock or one or more acute organ failures in the preceding 12 hours;
  • written informed consent obtained.

Exclusion

  • Pregnant or lactating women;
  • known HIV seropositive patients;
  • patients receiving immunosuppressive therapy or chronically using high doses of glucocorticosteroids (defined as \> 1 mg/kg/day) equivalent to prednisone 1 mg/kg/day;
  • patients expected to have rapidly fatal disease within 24 h;
  • known confirmed gram-positive sepsis;
  • known confirmed fungal sepsis;
  • chronic renal failure requiring haemodialysis or peritoneal dialysis;
  • acute pancreatitis with no established source of infection;
  • patients not expected to survive for 28 days due to other medical conditions such as end-stage neoplasm or other diseases;
  • participation in another investigational study within 90 days prior to start of the study which might interfere with this study;
  • previous administration of AP;
  • known allergy for cow milk.

Key Trial Info

Start Date :

September 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2006

Estimated Enrollment :

37 Patients enrolled

Trial Details

Trial ID

NCT00430859

Start Date

September 1 2004

End Date

March 1 2006

Last Update

April 2 2012

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

Hospital Network Antwerpen - Middelheim

Antwerp, Antwerpen, Belgium, B-2020

2

University Hospital Antwerpen

Antwerp, Antwerpen, Belgium, B-2650

3

University Hospital Vrije Universiteit Brussel

Brussels, Brussels Capital, Belgium, B-1090

4

University Medical Centre St. Radboud

Nijmegen, Gelderland, Netherlands, 6500 HB